AMPK activity was significantly higher in HSVECs from patients with CAD and T2D than in those from patients with CAD alone (0.062±0.011 compared with 0.031±0.005; P=0.01; Figure 3A). The gene discussed is PRKAA2; the disease is coronary artery disorder.